|
|
| 1.20 Data as of Dec 20 |  0.00 / 0.00%Today’s Change | 0.99 Today|||52-Week Range 3.45 | -49.58% Year-to-Date |
| Update on Coronado's TSO - Analyst Blog Dec 16 / Zacks.com | New Data from Sangamo - Analyst Blog Dec 11 / Zacks.com |
| Endocyte Enrolls First Patient in Study - Analyst Blog Dec 13 / Zacks.com | Preliminary Data from KaloBios' KB004 - Analyst Blog Dec 11 / Zacks.com |
| SUPN Presents Data on Drugs at AES - Analyst Blog Dec 13 / Zacks.com | ARIAD Loses as EMA Deliberates on Iclusig - Analyst Blog Dec 09 / Zacks.com |
| Previous close | 1.20 |
| Today’s open | 1.22 |
| Day’s range | 1.19 - 1.23 |
| Volume | 1,225,589 |
| Average volume (3 months) | 1,263,794 |
| Market cap | $54.2M |
| Dividend yield | -- |
| Earnings growth (last year) | +40.80% |
| Earnings growth (this year) | +139.25% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -6.62% |
| P/E ratio | -- |
| Price/Sales | 1.40 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CDXSCodexis Inc | -0.01 | -0.77% |
| IMUCImmunoCellular Thera... | +0.08 | +11.66% |
| ENMDEntreMed Inc | +0.02 | +1.25% |
| STEMStemCells Inc | +0.03 | +2.46% |
| Next reporting date | March 25, 2014 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $33.7M |
| Annual profit (last year) | -$20.4M |
| Net profit margin | -60.63% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director David A. Dodd |
Chief Financial Officer & Senior Vice President Dennis Turpin |
Corporate headquarters Québec, Quebec |
.
